Reduction of extended-release tacrolimus dose in low immunological risk kidney transplant recipients increases risk of rejection and appearance of DSA - a randomized study - Université de Bretagne Occidentale Access content directly
Journal Articles American Journal of Transplantation Year : 2016

Reduction of extended-release tacrolimus dose in low immunological risk kidney transplant recipients increases risk of rejection and appearance of DSA - a randomized study

Antoine Durrbach
Nicolas Bouvier
  • Function : Author
Anne-Elisabeth Heng
  • Function : Author
  • PersonId : 1203054

Domains

Immunology
No file

Dates and versions

hal-01400266 , version 1 (21-11-2016)

Identifiers

  • HAL Id : hal-01400266 , version 1
  • PUBMED : 27862923

Cite

Philippe Gatault, Nassim Kamar, Matthias Buchler, Charlotte Colosio, Dominique Bertrand, et al.. Reduction of extended-release tacrolimus dose in low immunological risk kidney transplant recipients increases risk of rejection and appearance of DSA - a randomized study. American Journal of Transplantation, 2016. ⟨hal-01400266⟩
157 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More